Poland updates drug reimbursement, mulls over other bills
This article was originally published in Scrip
Poland's new drug reimbursement regulation came into force on 16 December. Other changes aimed at reforming healthcare, such as a bill on therapeutic activity paving the way for the privatisation, through partnerships, of hospitals, and changes to the state health insurance policy, are at various stages of preparation and may follow soon.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.